Zelira Therapeutics Ltd.

Zelira Therapeutics Ltd. is a pharmaceutical and biotechnology company specializing in the development and commercialization of cannabinoid-based formulations. Its primary function is to research, innovate, and bring to market health solutions derived from cannabis, targeting a broad spectrum of medical conditions. Notable for its focus on pain management, sleep disorders, and dermatological issues, Zelira works at the intersection of traditional pharmaceuticals and emerging cannabis therapies. Through strategic partnerships and scientific collaborations, the company seeks to enhance patient outcomes and expand treatment functionalities across various clinical settings. Zelira Therapeutics is significant in the global biopharmaceutical market as it leverages cutting-edge cannabinoid research to meet increasing demands for alternative therapy options. Its contributions are pivotal in advancing the understanding and application of medicinal cannabis, helping to pioneer new pathways within modern healthcare.